EN DE
Watch Yung Zip Chemical Ind Co Ltd for free: once a week we email you where price and fair value stand.
Data-driven stock valuation

Yung Zip Chemical Ind Co Ltd (4102) fair value: what the stock is really worth

As of Nov 20, 2026: fair value (intrinsic value) of Yung Zip Chemical Ind Co Ltd stock NT$4.27, price NT$16.70, that is 74.4% below the price, quality 40 out of 100. Rating: strongly overvalued. Calculated from audited financials with 2 of our 26 valuation models and 37 quality factors, updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Healthcare TW · ISIN TW0004102009

YZ Yung Zip Chemical Ind Co Ltd logo Thin data Nov 15, 2026

Yung Zip Chemical Ind Co Ltd

4102 · TWO

Far too expensive (fair value 74% below the price), weak company and falling price: meets none of the 3 rules.

Follow free in the weekly email
Low debt 
Revenue last quarter +20% vs. a year ago. 
Quality 40/100 
Mixed vs. peers (5/12) 
Fair value NT$4.27 · Strongly overvalued 
Falling price (downtrend) 
Weak Growth (revenue 5y +0.5 %/yr in TWD) 
Loss-making · -0.1% net margin (TTM) 
Negative free cash flow 
Narrow moat 16/100 · thin data
Thin data 
Watch Yung Zip Chemical Ind Co Ltd for free: once a week we email you where price and fair value stand. Watch for free

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

NT$40.00 NT$14.96 Fair Value NT$4.27 Jun 2021 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 15, 2026.

How to read this chart

60‑month range NT$14.96 – NT$40.00 · fair‑value band NT$2.87 – NT$5.68 · the NT$16.70 price screens above the NT$4.27 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 15, 2026.

Follow Yung Zip Chemical Ind Co in your weekly email

Every Wednesday you see whether Yung Zip Chemical Ind Co is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Yung Zip Chemical Ind. Co., Ltd., together with its subsidiaries, engages in the manufacturing and trading of active pharmaceutical ingredients in Taiwan, China, Asia, the Americas, and internationally.

Show moreShow less

The company offers active pharmaceutical ingredients and excipients, API intermediates, and specialty chemicals. It is also involved in custom research and manufacturing services; general investments; and food manufacturing. The company was founded in 1978 and is based in Taichung, Taiwan.

Stock analysis

Yung Zip Chemical Ind Co Ltd (4102) currently trades at NT$16.70, while our model-based Fair Value estimate is NT$4.27, 74% below the price, so the stock looks overvalued today.

Show more

Valuation

How firm this estimate is: it rests on 2 models at a data quality of 82/100, which puts the data coverage at low.

Scenario range: NT$2.87 (bear) to NT$5.68 (bull), the price of NT$16.70 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 40/100 (below-average quality), in the Healthcare sector.

Weak Growth: Growth has flattened: the last year, three and five years all grew more slowly than the long-term average.

Yung Zip Chemical Ind Co Ltd reported revenue of 474M TWD in FY2025 versus 478M TWD in FY2021, a compound −0.2%/yr. Reported net income was −14.4M TWD in FY2025.

Key figures

Market cap 708M TWD (≈ $21.5M) Micro · P/S ratio 1.60 · EPS (TTM) NT$-0.02 · Dividend yield 6.5% · Net margin −0.1% · Return on equity 0.6% · Return on assets (EBIT) 4.0% (5-year average) · Operating margin 2.4%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 16 out of 100 (low confidence).

What moves the price

The share trades about 20% below its 52-week high and at its 52-week low, currently below its 200-day average.

For context, the median of 10 Healthcare peers we cover trades at −3% fair-value upside, at −74%, 4102 screens richer than that median.

Fair Value models

Bear NT$2.87 Fair Value NT$4.27 Bull NT$5.68
Price NT$16.70 · Downside -74.4%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
EV/EBITDA NT$2.87 NT$4.27 NT$5.68 66
NCAV (Graham) NT$0.4300 NT$0.6500 NT$0.8200 54
All 2 models by family
Multiples
EV/EBITDA NT$2.87 NT$4.27 NT$5.68 66
Asset-Based
NCAV (Graham) NT$0.4300 NT$0.6500 NT$0.8200 54

Open the full fair value analysis →

Quality Score breakdown

Overall quality 40/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 15
How much profit the company makes from its sales and capital
Quality Growth 1
Are margins and returns getting better?
Cashflow 4
Do the profits arrive as real cash?
Financial strength 75
Debt, balance sheet and risk of trouble
Investment 87
Does it invest with discipline instead of growing at any price?
Low Volatility 96
How calm the share price moves, does not count
Price momentum 29
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 2
Distance to the 52-week high, does not count
New shares 82
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 6/100
Growth has flattened: the last year, three and five years all grew more slowly than the long-term average.
Revenue growth 1 year
−18.8%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−5.8%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+0.5%
Start year 2020 (pandemic). Over 10 years: +4.1% a year
Revenue growth 23 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+3.2%
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
6.5% (2020) → −4.2% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed

4102 screens overvalued: fair value 74% below the price. Compare with Eli Lilly and Company →

Compare Yung Zip Chemical Ind Co Ltd with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Drug Manufacturers - General · 71 stocks

Beats the industry median on 5/12 measures
A mixed picture versus its industry peers.
Valuation
Quality Score 40 · Bottom 25%
Fair Value upside −74.4% · Bottom 25%
Profitability
Return on equity (12 months) 0.6% · Bottom 25%
Return on assets −1.6% · Bottom 25%
Net margin (12 months) −0.1% · Bottom 25%
Operating margin (12 months) 2.4% · Bottom 25%
Growth and dividend
Revenue growth (quarter YoY) 20.1% · Top 25%
Dividend yield (12 months) 6.5% · Top 25%
Balance sheet
Debt / equity 0.08× · Below median

Valuation Multiplesvs Drug Manufacturers - General median · lower = cheaper

P/B 1.20× · Cheaper than median
P/S (12 months) 1.43× · Cheaper than median
EV/EBITDA 29.7× · Priciest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)0 · sector 29
FUTURE (revenue growth)100 · sector 36
PAST (return on equity)2 · sector 41
HEALTH (low debt)96 · sector 92
DIVIDEND (yield)100 · sector 37

VALUE 0: the price sits above our fair-value range.

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Drug Manufacturers - General stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
Bristol-Myers Squibb Company BMY $58.80 $75.91 +29% vs 4102
Amgen Inc AMGN $435.64 $479.20 +10% vs 4102
Gilead Sciences, Inc GILD $166.43 $183.07 +10% vs 4102
Novartis AG NOVN CHF 127.76 CHF 123.50 −3% vs 4102
Merck & Co MRK $133.72 $129.26 −3% vs 4102
Pfizer Inc PFE $27.40 $24.87 −9% vs 4102
AbbVie Inc ABBV $286.20 $259.62 −9% vs 4102
Roche Holding RO CHF 402.60 CHF 326.56 −19% vs 4102
Johnson & Johnson, JNJ $270.47 $169.03 −38% vs 4102
Eli Lilly and Company LLY $1,347.11 $749.92 −44% vs 4102

Explore undervalued stocks

More undervalued Healthcare stocks →

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Yung Zip Chemical Ind Co Ltd: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "Yung Zip Chemical Ind Co Ltd Fair Value". https://www.fairvalue-calculator.com/stock/4102

Frequently asked questions

Is Yung Zip Chemical Ind Co Ltd (4102) overvalued or undervalued?
As of Nov 15, 2026, our model estimates a fair value of NT$4.27 versus a price of NT$16.70, about 74% lower (overvalued).
What is the fair value of 4102?
Our model-based fair value for Yung Zip Chemical Ind Co Ltd is NT$4.27 (as of Nov 15, 2026), built from audited fundamentals. The current price: NT$16.70.
What is the quality score of 4102?
Yung Zip Chemical Ind Co Ltd has a Quality Score of 40/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Yung Zip Chemical Ind Co Ltd (4102)?
We do not set a price target; the yardstick is the fair value of NT$4.27 (as of Nov 15, 2026) from 2 valuation models. Cautious scenario NT$2.87, optimistic scenario NT$5.68. It is a calculation from audited fundamentals, not an analyst target.
What is the Yung Zip Chemical Ind Co Ltd stock forecast for 2026?
Our models put fair value at NT$4.27, about 74% lower versus a price of NT$16.70 (overvalued). Cautious scenario NT$2.87, optimistic scenario NT$5.68. The calculation is refreshed regularly with new filings.
What is the revenue of Yung Zip Chemical Ind Co Ltd (4102)?
Yung Zip Chemical Ind Co Ltd reported trailing-twelve-month revenue of about 494M TWD (latest available figure, as of Nov 15, 2026).
Does Yung Zip Chemical Ind Co Ltd pay a dividend?
Yung Zip Chemical Ind Co Ltd currently shows a dividend yield of 6.53% relative to its recent price (as of Nov 15, 2026).
How much is the dividend of Yung Zip Chemical Ind Co Ltd (4102)?
Yung Zip Chemical Ind Co Ltd has a dividend yield of 6.5%.
What is the intrinsic value of Yung Zip Chemical Ind Co Ltd (4102)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Yung Zip Chemical Ind Co Ltd it is NT$4.27 per share (as of Nov 15, 2026), against a price of NT$16.70. It is the blended result of 2 valuation models in 2 families (Multiples, Asset-Based).
Is Yung Zip Chemical Ind Co Ltd stock overvalued or undervalued in 2026?
As of Nov 15, 2026, 4102 trades above its calculated fair value: price NT$16.70, fair value NT$4.27, a gap of about −74% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 4102?
No. The price is what the market pays today (NT$16.70); the fair value is what the company's own numbers justify (NT$4.27). For Yung Zip Chemical Ind Co Ltd the two are NT$12.43 per share apart. That gap is exactly why we show both numbers side by side.
How much is Yung Zip Chemical Ind Co Ltd worth?
The market values Yung Zip Chemical Ind Co Ltd at about 708M TWD (market capitalisation, as of Nov 15, 2026). Per share that is NT$16.70; our models calculate a fair value of NT$4.27 per share.
What do the bullish and bearish scenarios say about 4102?
Our models span a range for Yung Zip Chemical Ind Co Ltd: cautious scenario NT$2.87, base NT$4.27, optimistic NT$5.68 per share (as of Nov 15, 2026, price NT$16.70). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Yung Zip Chemical Ind Co Ltd (4102)?
Balance-sheet figures for Yung Zip Chemical Ind Co Ltd (as of Nov 15, 2026): return on equity 0.6%, debt of 0.08 per unit of equity. They feed the Quality Score of 40/100, which measures business quality independently of the share price.
How far is 4102 from its 52-week high?
Yung Zip Chemical Ind Co Ltd trades at NT$16.70, about 20% below its 52-week high of NT$21.00 and at the low of NT$16.70 (as of Nov 20, 2026). Distance from the high says nothing about value: that is what the fair value of NT$4.27 is for.
Which stocks are comparable to Yung Zip Chemical Ind Co Ltd?
From the same area (Healthcare) we also value Eli Lilly and Company, Johnson & Johnson,, AbbVie Inc, Roche Holding, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Yung Zip Chemical Ind Co Ltd stock attractive at the current price?
The data as of Nov 15, 2026: price NT$16.70, calculated fair value NT$4.27 (−74%), Quality Score 40/100, from 2 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 4102 calculated?
We run Yung Zip Chemical Ind Co Ltd through 2 models from 2 families: Multiples, Asset-Based. Every model gets the same audited fundamentals; the fair value of NT$4.27 builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 10.1% above its aggregate fair value. Yung Zip Chemical Ind Co Ltd itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Yung Zip Chemical Ind Co Ltd (4102)?
The closing price on Nov 20, 2026 was NT$16.70. Our model-based fair value is NT$4.27, about 74% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Yung Zip Chemical Ind Co Ltd right now?
The price sits above even our optimistic bull case (NT$5.68). The favourable scenario is already priced in. Weak quality (40/100) and above fair value at the same time, the margin of safety is missing on both counts. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. A fairly wide model range (NT$2.87 to NT$5.68) leaves room in how you read the outcome.

Key figures of Yung Zip Chemical Ind Co Ltd

How large is the market capitalisation of Yung Zip Chemical Ind Co Ltd (4102)?
The market capitalisation of Yung Zip Chemical Ind Co Ltd is 708M TWD (≈ $21.5M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Yung Zip Chemical Ind Co Ltd (4102)?
The price-to-sales ratio of Yung Zip Chemical Ind Co Ltd is 1.60 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Yung Zip Chemical Ind Co Ltd (4102)?
Earnings per share at Yung Zip Chemical Ind Co Ltd are NT$-0.02. Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Yung Zip Chemical Ind Co Ltd (4102)?
The dividend yield of Yung Zip Chemical Ind Co Ltd is 6.5%. Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Yung Zip Chemical Ind Co Ltd (4102)?
The net margin of Yung Zip Chemical Ind Co Ltd is −0.1% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Yung Zip Chemical Ind Co Ltd (4102)?
The return on equity (ROE) of Yung Zip Chemical Ind Co Ltd is 0.6% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Yung Zip Chemical Ind Co Ltd (4102)?
On an EBIT basis the return on assets of Yung Zip Chemical Ind Co Ltd is 4.0% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Yung Zip Chemical Ind Co Ltd (4102)?
The operating margin of Yung Zip Chemical Ind Co Ltd is 2.4% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Yung Zip Chemical Ind Co Ltd (4102)?
Revenue at Yung Zip Chemical Ind Co Ltd is growing 20.1% in the last quarter versus the same quarter a year earlier (3y avg −5.8%). How much revenue grew in the last quarter versus the same quarter a year earlier (YoY). The 3-year average next to it puts the single quarter in context.
How fast are earnings growing at Yung Zip Chemical Ind Co Ltd (4102)?
Earnings per share at Yung Zip Chemical Ind Co Ltd are growing 490% in the last quarter versus the same quarter a year earlier. How much earnings per share grew in the last quarter versus the same quarter a year earlier.
How much free cash flow does Yung Zip Chemical Ind Co Ltd (4102) generate?
The free cash flow of Yung Zip Chemical Ind Co Ltd is −46.2M TWD (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Yung Zip Chemical Ind Co Ltd (4102) carry?
The net debt of Yung Zip Chemical Ind Co Ltd is 57.0M TWD (fiscal year 2025). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch Yung Zip Chemical Ind Co Ltd in the live analysis

One click puts Yung Zip Chemical Ind Co Ltd on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 28,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.